To ask the Secretary of State for Health and Social Care, what his policy is on the availability of medicinal cannabis prescriptions for children with epilepsy; and if he will make a statement.
On 1 November 2018, the law was changed to allow clinicians on the General Medical Council’s (GMC) Specialist Register to prescribe cannabis-based products for medicinal use, where clinically appropriate and in the best interests of patients.
On 20 December 2019 a letter was published on the NHS England and NHS Improvement website reminding prescribers of the GMC’s guidance on the prescribing and use of unlicensed medicines – and to clarify the procedure for prescribing and supplying cannabis-based products for medicinal use. Licensed cannabis-based products indicated for epilepsy, such as Epidyolex, may be prescribed in-line with the condition of the marketing authorisation. The letter is available at the following link: